Article
Epigenetic biomarkers in lung cancer.
Cancer letters - 28 Jan 2014
Liloglou Triantafillos, Bediaga Naiara G, Brown Benjamin R B, Field John K, Davies Michael P A
Abstract excerpt
Lung cancer mortality is strongly associated with the predominant diagnosis of late stage lesions that hampers effective therapy. Molecular biomarkers for early lung cancer detection is an unmet public health need and the lung cancer research community worldwide is putting a lot of effort to utilise major lung cancer population programmes in order to develop such molecular tools. The study of cancer epigenetics...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
